Results 71 to 80 of about 7,735 (212)

Association between HIV and acquisition of rifamycin resistance with first-line TB treatment: a systematic review and meta-analysis

open access: yesBMC Infectious Diseases
Background Multi-drug or rifamycin-resistant tuberculosis (MDR/RR-TB) is an important public health concern, including in settings with high HIV prevalence.
Nesbert Zinyakatira   +2 more
doaj   +1 more source

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

open access: yesMemorias do Instituto Oswaldo Cruz, 2019
BACKGROUND Rifamycins are a group of antibiotics mainly used in the treatment of tuberculosis (TB), however they interact with antiretroviral therapy (ART).
Carolina Arana Stanis Schmaltz   +3 more
doaj   +1 more source

Clostridioides difficile as a Zoonotic and Foodborne Pathogen: Reviewing the Global Evidence and South African Data

open access: yesMicrobiologyOpen, Volume 15, Issue 3, June 2026.
Clostridioides difficile infections are increasingly problematic in areas with already burdened healthcare systems. From a One‐Health perspective, a lack of surveillance in developing countries greatly contributes to the limited information available on the zoonotic and foodborne potential of C. difficile.
M. Gouws, P. E. Strydom, D. Rip
wiley   +1 more source

Cefdinir reprograms Gram‐positive bacteria to synergize with lysozyme against superbugs

open access: yesmLife, Volume 5, Issue 3, Page 355-368, June 2026.
Abstract Multidrug‐resistant (MDR) bacteria pose a critical global health threat, urgently requiring solutions. Cefdinir, the highest‐selling third‐generation cephalosporin but one now facing clinical obsolescence due to escalating resistance, is conventionally classified as a nascent cell wall synthesis inhibitor.
Qi Zhang   +6 more
wiley   +1 more source

Systemic Absorption of Rifamycin SV MMX Administered as Modified-Release Tablets in Healthy Volunteers [PDF]

open access: yes, 2011
The new oral 200-mg rifamycin SV MMX modified-release tablets, designed to deliver rifamycin SV directly into the colonic lumen, offer considerable advantages over the existing immediate-release antidiarrheic formulations. In two pharmacokinetics studies
L. Loprete   +5 more
core   +1 more source

Diene Substitution Patterns in the Conformation‐Activity Relationships of GEX1A

open access: yesChemMedChem, Volume 21, Issue 10, 27 May 2026.
Synthetic analogues of GEX1A were designed and synthesised in an effort to explore the significance of diene substitution on the conformational preferences and expand our understanding of the three‐dimensional pharmacophore for this biologically active natural product.
Christian A. Umaña   +5 more
wiley   +1 more source

Postmastectomy life-threatening hypersensitivity reactions induced by rifamycin sv in companion animals: Evaluation of 7 cases [PDF]

open access: yes, 2018
Drug-induced hypersensitivity and adverse symptoms related to the high mortality remain as a major problem for veterinary practitioners. Although application of Rifamycin SV without intradermal susceptibility tests have been commonly used in wound ...
Hatice Esra Çolakoğlu   +7 more
core   +1 more source

Preparation of McAbs against rifamycin and development of A competitive ELISA method [PDF]

open access: yes, 2009
Objective: To prepare the monoclonal antobodies (McAbs) against rifamycin and develop a competive ELISA method. Methods: Rifamycin was coupled to bovine serum albumin (BSA) and ovalbumin (OVA) as carriers respectively.
Zhang, Yun Tao, Xie, Yong, Cao, Xin Yun
core   +1 more source

A Review of the Efficacy, Safety, and Feasibility of Rifamycin-Based Post-Exposure Chemoprophylaxis for Leprosy

open access: yesTropical Medicine and Infectious Disease
In 2021, the World Health Organization (WHO) recommended scaling up leprosy prevention activities, including chemoprophylaxis, as one of the pillars of their ‘Towards Zero Leprosy’ strategy.
Patrick O. Campbell   +2 more
doaj   +1 more source

Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin [PDF]

open access: yesMedicamentul Veterinar, 2015
The Microbiology Laboratory from the Institute for the Control of Veterinary Biological Products and Medicines participated in a collaborative study in order to determine the potency of rifamycin CRS, batch 4, according to the protocol sent by the EDQM ...
Simona Sturzu   +5 more
doaj  

Home - About - Disclaimer - Privacy